Reaktionsgleichung
[CH3:1][N:2]([CH2:4][C:5]1[O:9][C:8]([CH2:10][S:11][CH2:12][CH2:13][NH:14][C:15]([NH:20][CH3:21])=[CH:16][N+:17]([O-:19])=[O:18])=[CH:7][CH:6]=1)[CH3:3].[ClH:22]>C(O)(C)C>[CH3:21][NH:20][C:15]([NH:14][CH2:13][CH2:12][S:11][CH2:10][C:8]1[O:9][C:5]([CH2:4][N:2]([CH3:1])[CH3:3])=[CH:6][CH:7]=1)=[CH:16][N+:17]([O-:19])=[O:18].[ClH:22]Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
N-[2-[[[5-(Dimethylamino)methyl-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine (100 g) was dissolved in isopropanol (800 ml) containing molar equivalent of hydrogen chloride at 40°-50° C. The solution was stirred further for 1 hr. The hydrochloride crystallized during this period. The product was filtered off, washed with isopropanol twice (100 ml each) and was dried at 40° C. under vacuum to give Form 1 ranitidine hydrochloride (106 g), m.p. 137°-138° C., DSC peak temperature=143.4° C., purity=99.6% (HPLC).
Aufarbeitung
- customThe hydrochloride crystallized during this period
- filtrationThe product was filtered off
- washwashed with isopropanol twice (100 ml each)
- customwas dried at 40° C. under vacuum
Quellen und Nachweise
- ORD-Eintrag
- ord-fbb718ef9c3141218cc2c30a9d301eaa
- Quelldatensatz
- uspto-grants-1997_04
- Patentnummer
- US05621120
Verknüpfte Notizen
Wird geladen…